Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 2/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.56 |
| ▸ | ACE | P12821 | 1/20 | 0.54 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.49 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 7/20 | 0.48 |
| ▸ | CTSS | P25774 | 6/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.47 |
| ▸ | CTSB | P07858 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 5/20 | 0.47 |
| ▸ | PPARG | P37231 | 4/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.46 |
| ▸ | ITGAV | P06756 | 1/20 | 0.46 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22023204 | 1.00 | ITGB3 (0.56) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL2720546 | 0.90 | KLK5 (0.49) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL2480406 | 0.90 | KLK5 (0.49) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL8098713 | 0.87 | CTSK (0.49) | ACECTSKCTSSCTSLCTSB | |
| SCHEMBL2477418 | 0.85 | CTSS (0.53) | CTSKCTSSCTSLCTSBPTPN1 | |
| SCHEMBL1819429 | 0.84 | CTSK (0.41) | ITGB3ITGA2BACECTSKCTSS | |
| SCHEMBL5731512 | 0.83 | ACE (0.60) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL5731509 | 0.83 | ACE (0.60) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL5731514 | 0.83 | ACE (0.60) | ITGB3ITGA2BACEITGA4ITGB7 | |
| SCHEMBL6685168 | 0.82 | ITGB3 (0.79) | ITGB3ITGA2BACEITGA4PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388522-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | OSAKA UNIVERSITY (JP) | 2025-12-25 | — | — | US | disclosed |
| US-12421179-B2 | Production method for radiolabeled aryl compound | OSAKA UNIVERSITY (JP) | 2025-09-23 | — | — | US | disclosed |
| EP-3663307-B1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | UNIV OSAKA (JP) | 2024-10-02 | — | — | EP | disclosed |
| EP-4438608-A2 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | Osaka University (JP) | 2024-10-02 | — | — | EP | disclosed |
| US-20230331640-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | OSAKA UNIVERSITY (JP) | 2023-10-19 | — | — | US | disclosed |
| US-11731917-B2 | Production method for radiolabeled aryl compound | OSAKA UNIVERSITY (JP) | 2023-08-22 | — | — | US | disclosed |
| US-20200369578-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | OSAKA UNIVERSITY (JP) | 2020-11-26 | — | — | US | disclosed |
| EP-3663307-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | Osaka University (JP) | 2020-06-10 | — | — | EP | disclosed |
| US-9024093-B2 | Fluorination of organic compounds | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-05-05 | — | — | US | disclosed |
| WO-2012054782-A2 | FLUOROALKOXYLATION OF ORGANIC COMPOUNDS | PRESIDENTS AND FELLOWS OF HARVARD COLLEGE (US) | 2012-04-26 | — | — | WO | disclosed |
| US-20110312903-A1 | FLUORINATION OF ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2011-12-22 | — | — | US | disclosed |
| EP-2376408-A2 | FLUORINATION OF ORGANIC COMPOUNDS | President and Fellows of Harvard College (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2010059943-A2 | FLUORINATION OF ORGANIC COMPOUNDS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2010-05-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331640-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | NAT1, CAT, ARSA | ITGB3 2991/4885ITGA2B 2479/4885ACE 806/4885 |
| US-20250388522-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | CYP2C9, CYP2C19, CYP2B6 | ITGB3 2521/4885ITGA2B 2940/4885ACE 2758/4885 |
| US-11731917-B2 | Production method for radiolabeled aryl compound | NAT1, CAT, ARSA | ITGB3 2991/4885ITGA2B 2479/4885ACE 806/4885 |
| US-20200369578-A1 | PRODUCTION METHOD FOR RADIOLABELED ARYL COMPOUND | NAT1, CAT, ARSA | ITGB3 2991/4885ITGA2B 2479/4885ACE 806/4885 |
| US-20110312903-A1 | FLUORINATION OF ORGANIC COMPOUNDS | SLCO1B3, SLCO2B1, FLI1 | ITGB3 323/4885ITGA2B 961/4885ACE 3215/4885 |
| US-12421179-B2 | Production method for radiolabeled aryl compound | NAT1, CAT, ARSA | ITGB3 2991/4885ITGA2B 2479/4885ACE 806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.